ARTIVION INC (AORT) — insider trading
Health Care · NYSE
ARTIVION INC (AORT) has 24 reported SEC Form 4 insider transactions in our data, including 9 open-market sales among the most recent 24 (latest 2026-09-10).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-10 | GREEN ANDREW M | Officer (SVP, Regulatory and Quality) | Open-market sale | 11,480 | $24.97 | $286.7K | Form 4 |
| 2026-09-03 | GREEN ANDREW M | Officer (SVP, Regulatory and Quality) | Open-market sale | 1,493 | $26.02 | $38.8K | Form 4 |
| 2026-09-02 | GREEN ANDREW M | Officer (SVP, Regulatory and Quality) | Open-market sale | 6,510 | $27.27 | $177.5K | Form 4 |
| 2026-08-19 | Mackin James P | Officer (President & CEO) | Open-market sale | 70,000 | $28.96 | $2.03M | Form 4 |
| 2026-08-14 | Berry Lance A | Officer (EVP, COO, CFO & Treasurer) | Open-market sale | 715 | $28.55 | $20.4K | Form 4 |
| 2026-08-14 | GREEN ANDREW M | Officer (SVP, Regulatory and Quality) | Open-market sale | 616 | $28.55 | $17.6K | Form 4 |
| 2026-08-12 | Holloway Jean F | Officer (SVP, General Counsel) | Open-market sale | 977 | $28.49 | $27.8K | Form 4 |
| 2026-06-11 | GREEN ANDREW M | Officer (SVP, Regulatory and Quality) | Option exercise / conversion (derivative) | 30,000 | — | $0 | Form 4 |
| 2026-06-11 | GREEN ANDREW M | Officer (SVP, Regulatory and Quality) | Option exercise / conversion (derivative) | 14,001 | — | $0 | Form 4 |
| 2026-06-11 | GREEN ANDREW M | Officer (SVP, Regulatory and Quality) | Open-market sale | 30,000 | $20.69 | $620.8K | Form 4 |
| 2026-06-11 | GREEN ANDREW M | Officer (SVP, Regulatory and Quality) | Option exercise / conversion | 30,000 | $11.03 | $330.9K | Form 4 |
| 2026-06-11 | GREEN ANDREW M | Officer (SVP, Regulatory and Quality) | Open-market sale | 14,001 | $20.71 | $289.9K | Form 4 |
| 2026-06-11 | GREEN ANDREW M | Officer (SVP, Regulatory and Quality) | Option exercise / conversion | 14,001 | $18.44 | $258.2K | Form 4 |
| 2026-06-02 | SEMEDO ANTHONY B. | Director | Other acquisition or disposition | 6,325 | — | $0 | Form 4 |
| 2026-06-02 | SEMEDO ANTHONY B. | Director | Other acquisition or disposition | 6,325 | — | $0 | Form 4 |
| 2026-05-18 | ACKERMAN THOMAS F | Director | Grant / award / vesting | 7,576 | — | $0 | Form 4 |
| 2026-05-18 | BEVEVINO DANIEL J | Director | Grant / award / vesting | 7,576 | — | $0 | Form 4 |
| 2026-05-18 | Bullock James | Director | Grant / award / vesting | 7,576 | — | $0 | Form 4 |
| 2026-05-18 | Burbank Jeffrey H | Director | Grant / award / vesting | 7,576 | — | $0 | Form 4 |
| 2026-05-18 | Hoff Elizabeth A | Director | Grant / award / vesting | 7,576 | — | $0 | Form 4 |
| 2026-05-18 | Salveson Jon W | Director | Grant / award / vesting | 7,576 | — | $0 | Form 4 |
| 2026-05-18 | SEMEDO ANTHONY B. | Director | Grant / award / vesting | 7,576 | — | $0 | Form 4 |
| 2026-05-18 | Borgstrom Marna P | Director | Grant / award / vesting | 7,576 | — | $0 | Form 4/A |
| 2026-05-14 | Borgstrom Marna P | Director | Grant / award / vesting | 7,850 | — | $0 | Form 4 |
Ask the chat about AORT's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: ARTIVION INC (AORT).
Last updated 2026-09-10 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.